MedPath

TILGANGA INSTITUTE OF OPHTHALMOLOGY

🇳🇵Nepal
Ownership
-
Established
1994-01-01
Employees
-
Market Cap
-
Website
http://www.tilganga.org

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction

Not Applicable
Conditions
Hyperopia
First Posted Date
2014-12-12
Last Posted Date
2018-04-25
Lead Sponsor
Tilganga Institute of Ophthalmology
Target Recruit Count
220
Registration Number
NCT02316041
Locations
🇳🇵

Tilganga Institute of Ophthalmology, Refractive Surgery Unit, Kathmandu, Nepal

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.